128 related articles for article (PubMed ID: 37292906)
1. Mitochondrial citrate carrier SLC25A1 is a dosage-dependent regulator of metabolic reprogramming and morphogenesis in the developing heart.
Ohanele C; Peoples JN; Karlstaedt A; Geiger JT; Gayle AD; Ghazal N; Sohani F; Brown ME; Davis ME; Porter GA; Faundez V; Kwong JQ
bioRxiv; 2024 May; ():. PubMed ID: 37292906
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.
Chaouch A; Porcelli V; Cox D; Edvardson S; Scarcia P; De Grassi A; Pierri CL; Cossins J; Laval SH; Griffin H; Müller JS; Evangelista T; Töpf A; Abicht A; Huebner A; von der Hagen M; Bushby K; Straub V; Horvath R; Elpeleg O; Palace J; Senderek J; Beeson D; Palmieri L; Lochmüller H
J Neuromuscul Dis; 2014; 1(1):75-90. PubMed ID: 26870663
[TBL] [Abstract][Full Text] [Related]
3. Loss of the mitochondrial citrate carrier,
Kasprzyk-Pawelec A; Tan M; Phua YL; Rahhal R; McIntosh A; Fernandez H; Mosaoa R; Girgis M; Cheema A; Jiang L; Kroemer LF; Popratiloff A; Clarkson C; Kirmsa BM; Pearson GW; Glasgow E; Albanese C; Vockley J; Avantaggiati ML
bioRxiv; 2024 Feb; ():. PubMed ID: 37503155
[TBL] [Abstract][Full Text] [Related]
4. SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer.
Yang Y; He J; Zhang B; Zhang Z; Jia G; Liu S; Wu T; He X; Wang N
Cell Death Dis; 2021 Nov; 12(12):1108. PubMed ID: 34839347
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.
Tan M; Mosaoa R; Graham GT; Kasprzyk-Pawelec A; Gadre S; Parasido E; Catalina-Rodriguez O; Foley P; Giaccone G; Cheema A; Kallakury B; Albanese C; Yi C; Avantaggiati ML
Cell Death Differ; 2020 Jul; 27(7):2143-2157. PubMed ID: 31959914
[TBL] [Abstract][Full Text] [Related]
6. The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia.
Hlouschek J; Hansel C; Jendrossek V; Matschke J
Front Oncol; 2018; 8():170. PubMed ID: 29888201
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.
Fernandez HR; Gadre SM; Tan M; Graham GT; Mosaoa R; Ongkeko MS; Kim KA; Riggins RB; Parasido E; Petrini I; Pacini S; Cheema A; Varghese R; Ressom HW; Zhang Y; Albanese C; Üren A; Paige M; Giaccone G; Avantaggiati ML
Cell Death Differ; 2018 Jul; 25(7):1239-1258. PubMed ID: 29651165
[TBL] [Abstract][Full Text] [Related]
8. A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation.
Infantino V; Iacobazzi V; Menga A; Avantaggiati ML; Palmieri F
Biochim Biophys Acta; 2014 Nov; 1839(11):1217-1225. PubMed ID: 25072865
[TBL] [Abstract][Full Text] [Related]
9. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
Cohen I; Staretz-Chacham O; Wormser O; Perez Y; Saada A; Kadir R; Birk OS
Am J Med Genet A; 2018 Feb; 176(2):330-336. PubMed ID: 29226520
[TBL] [Abstract][Full Text] [Related]
10. New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.
Santarsiero A; Leccese P; Convertini P; Padula A; Abriola P; D'Angelo S; Bisaccia F; Infantino V
Mediators Inflamm; 2018; 2018():1419352. PubMed ID: 30050389
[TBL] [Abstract][Full Text] [Related]
11. The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond.
Mosaoa R; Kasprzyk-Pawelec A; Fernandez HR; Avantaggiati ML
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499062
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria.
Nota B; Struys EA; Pop A; Jansen EE; Fernandez Ojeda MR; Kanhai WA; Kranendijk M; van Dooren SJ; Bevova MR; Sistermans EA; Nieuwint AW; Barth M; Ben-Omran T; Hoffmann GF; de Lonlay P; McDonald MT; Meberg A; Muntau AC; Nuoffer JM; Parini R; Read MH; Renneberg A; Santer R; Strahleck T; van Schaftingen E; van der Knaap MS; Jakobs C; Salomons GS
Am J Hum Genet; 2013 Apr; 92(4):627-31. PubMed ID: 23561848
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.
Napoli E; Tassone F; Wong S; Angkustsiri K; Simon TJ; Song G; Giulivi C
J Biol Chem; 2015 Sep; 290(38):23240-53. PubMed ID: 26221035
[TBL] [Abstract][Full Text] [Related]
14. Expanding the Clinical Spectrum of Mitochondrial Citrate Carrier (SLC25A1) Deficiency: Facial Dysmorphism in Siblings with Epileptic Encephalopathy and Combined D,L-2-Hydroxyglutaric Aciduria.
Prasun P; Young S; Salomons G; Werneke A; Jiang YH; Struys E; Paige M; Avantaggiati ML; McDonald M
JIMD Rep; 2015; 19():111-5. PubMed ID: 25614306
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis.
Majd H; King MS; Smith AC; Kunji ERS
Biochim Biophys Acta Bioenerg; 2018 Jan; 1859(1):1-7. PubMed ID: 29031613
[TBL] [Abstract][Full Text] [Related]
16. The citrate transporters SLC13A5 and SLC25A1 elicit different metabolic responses and phenotypes in the mouse.
Fernandez-Fuente G; Overmyer KA; Lawton AJ; Kasza I; Shapiro SL; Gallego-Muñoz P; Coon JJ; Denu JM; Alexander CM; Puglielli L
Commun Biol; 2023 Sep; 6(1):926. PubMed ID: 37689798
[TBL] [Abstract][Full Text] [Related]
17. A conserved role for the mitochondrial citrate transporter Sea/SLC25A1 in the maintenance of chromosome integrity.
Morciano P; Carrisi C; Capobianco L; Mannini L; Burgio G; Cestra G; De Benedetto GE; Corona DF; Musio A; Cenci G
Hum Mol Genet; 2009 Nov; 18(21):4180-8. PubMed ID: 19654186
[TBL] [Abstract][Full Text] [Related]
18. [Congenital myasthenic syndrome related to SLC25A1 gene variant: two cases report and literature review].
Li WH; Wu BB; Zhou SZ
Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):42-46. PubMed ID: 33397003
[No Abstract] [Full Text] [Related]
19. A case report of an intermediate phenotype between congenital myasthenic syndrome and D-2- and L-2-hydroxyglutaric aciduria due to novel SLC25A1 variants.
Li W; Zhang M; Zhang L; Shi Y; Zhao L; Wu B; Li X; Zhou S
BMC Neurol; 2020 Jul; 20(1):278. PubMed ID: 32660532
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive Pancreatic Tumorigenesis.
Zhang R; Peng X; Du JX; Boohaker R; Estevao IL; Grajeda BI; Cox MB; Almeida IC; Lu W
Cancer Res; 2023 Nov; 83(22):3739-3752. PubMed ID: 37695315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]